{"nct_id":"NCT07155187","title":"A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer","status":"NOT_YET_RECRUITING","status_verified_date":"2025-08","start_date":"2025-11-15","start_date_type":"ESTIMATED","primary_completion_date":"2031-08","primary_completion_date_type":"ESTIMATED","completion_date":"2031-08","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["ABBV"]}